Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
- ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available
- Deborah Waterhouse, CEO of ViiV Healthcare, to join GSK Corporate Executive Team (CET)
Tweets from GSK US
-
GSKUS @GSKUS
We’re proud to have received 100% on @HRC 's Corporate Equality Index for the 14th consecutive year. At GSK, we strive to create a safe environment where everyone can bring their best and most authentic selves to work. #CEI2020 #LGBTQ See full index 👉gsk.to/36jPDNTo
about 3 days ago
T
-
GSKUS @GSKUS
#NEWS The @US_FDA has granted priority review of our application for a new treatment that may help patients with relapsed or refractory multiple #myeloma Read more: gsk.to/37gGyq3 #bloodcancer
about 3 days ago -
GSKUS @GSKUS
On #MLKDay, we’re honoring our commitment to extend #volunteering opportunities to all our employees to bring positive change in our local communities and #globalhealth. #Dayofservice gsk.to/3745AJb
about 4 days ago
